Home LiteratureArticle Details
PMID: 376558 Published · ppublish English Journal Article

Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.

The Journal of clinical investigation ·Vol. 64 ·No. 1 ·1979-07-00 ·Pages 280-6

Gadek JE, Hosea SW, Gelfand JA, Frank MM

Abstract

Hereditary angioedema (HAE), an auto-somal dominant disorder characterized by attacks of episodic edema is associated with decreased functional levels of the C1 esterase inhibitor. Approximately 85% of patients have lowered antigen levels of a normal inhibitor protein. 15% of patients have normal or elevated antigenic levels of functionless protein. We have examined the response to danazol therapy of patients with the variant HAE phenotypes possessing the abnormal protein in an effort to determine if these patients possess a normal structural C1 inhibitor allele. Four patients with a variant HAE phenotype were treated successfully with danazol. In two patients, distinguished by the presence of a functionless, albumin-bound, C1 inhibitor (phenotype 2), phenotypic analysis of the danazol response by bidirectional immunoelectrophoresis revealed the appearance of the normal C1 inhibitor gene product during danazol therapy. This relatively cathodal C1 inhibitor peak appears in conjunction with the development of nearly normal functional activity. All of the functional C1 inhibitory activity which appeared in the phenotype 2 treatment serum was associated with the electrophoretically normal inhibitor. This normal protein could be separated from the functionless inhibitor protein by immunoadsorption and molecular sieve chromatography. Danazol therapy of the two patients with an electrophoretically normal, functionless C1 inhibitor (phenotype 3) also resulted in a clinical remission associated with development of a significant increment in functional serum C1 inhibitory activity and C1 inhibitor protein. These findings demonstrate that these two HAE phenotypic variants are heterozygous for the normal serum C1 inhibitor, a finding which was not apparent before phenotypic analysis of this serum during danazol therapy. These data provide strong evidence for a basic similarity between the common form of HAE and its phenotypic variants. They also suggest that a structural gene lesion may result in the abnormalities of serum C1 inhibitor function and disease expression in all three of these HAE phenotypes.

MeSH Terms
Angioedema/drug therapy,genetics,immunology Chromatography, Gel Complement C1 Inactivator Proteins/analysis,genetics Danazol/therapeutic use Humans Immunoelectrophoresis Immunosorbent Techniques Phenotype Pregnadienes/therapeutic use Protein Binding Serum Albumin/analysis
Chemicals
Complement C1 Inactivator Proteins Pregnadienes Serum Albumin Danazol
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gadek J E
Hosea S W
Gelfand J A
Frank M M
References (17)
17 references, click to expand
  1. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
    Anal Biochem. 1965 Feb;10:358-61 PMID: 14302464
  2. Assay and properties of serum inhibitor of C'l-esterase.
    Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608-11 PMID: 14416422
  3. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.
    Am J Med. 1963 Jul;35:37-44 PMID: 14046003
  4. HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.
    Science. 1965 May 14;148(3672):957-8 PMID: 14277836
  5. ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.
    J Clin Invest. 1964 Nov;43:2204-13 PMID: 14223932
  6. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.
    N Engl J Med. 1976 Dec 23;295(26):1444-8 PMID: 792688
  7. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.
    J Clin Invest. 1971 Oct;50(10):2143-9 PMID: 4107267
  8. The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.
    Immunochemistry. 1969 Jan;6(1):53-66 PMID: 4179831
  9. Alpha1-antitrypsin and its deficiency.
    Am Rev Respir Dis. 1974 Aug;110(2):176-94 PMID: 4212922
  10. Long-term therapy of hereditary angioedema (HAE). Preventive management with fluoxymesterone and oxymetholone in severely affected males and females.
    Johns Hopkins Med J. 1974 Dec;135(6):391-8 PMID: 4216720
  11. The genetics of hereditary angioedema: a hypothesis.
    Clin Genet. 1973 Jun;4(6):494-9 PMID: 4207178
  12. Familial thrombosis due to antithrombin 3 deficiency.
    Blood. 1974 Feb;43(2):219-31 PMID: 4810073
  13. The isolation of IgG from mammalian sera with the aid of caprylic acid.
    Arch Biochem Biophys. 1969 Nov;134(2):279-84 PMID: 4982185
  14. The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.
    J Immunol. 1968 Jun;100(6):1154-64 PMID: 4972183
  15. Hereditary angioedema: the clinical syndrome and its management.
    Ann Intern Med. 1976 May;84(5):580-93 PMID: 1275365
  16. C1 inactivator protein complexed with albumin in plasma from a patient with angioneurotic edema.
    Eur J Immunol. 1971 Apr;1(2):146-9 PMID: 5127392
  17. Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.
    J Clin Invest. 1969 Apr;48(4):642-53 PMID: 5813121
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1979-07-00
Pages
280-6
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC372115
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]